Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Innovent
Biotech
Innovent's anti-VEGF drug matches Eylea in eye disease trial
Innovent’s anti-VEGF drug held its own against Regeneron and Bayer’s blockbuster eye disease therapy Eylea in a phase 2 trial.
James Waldron
Mar 19, 2024 10:36am
Next-gen Lilly obesity drug slashes weight in Innovent study
May 11, 2023 8:55am
Sanofi expands Innate tumor collab
Dec 19, 2022 7:30am
Innovent pays nearly $100M for China rights to LG Chem gout med
Dec 15, 2022 10:10am
Innovent catching up with Lilly, Novo Nordisk with obesity data
Jun 8, 2022 9:45am